Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Results 1 - 20 of 73 : 1 2 3 4 Next »

Recs

0
Member Avatar OklaBoston (67.43) Submitted: 9/9/2014 4:36:47 AM : Underperform Start Price: $14.19 KERX Score: +4.93

Had a good run but now overpriced with a worrisome amount of insider open market selling.

As a believer in the idea that insiders buy low and sell high I pretty much have to be bearish on this.

Recs

0
Member Avatar keelfoot (< 20) Submitted: 6/26/2014 11:20:30 AM : Outperform Start Price: $15.55 KERX Score: -15.64

Getting close to success with key much needed diabetes drugs.

Recs

0
Member Avatar 78taxs (< 20) Submitted: 6/24/2014 12:08:55 PM : Outperform Start Price: $15.49 KERX Score: -14.48

treatment for diabetes

Recs

0
Member Avatar Redbeagle (36.65) Submitted: 5/23/2014 11:37:37 AM : Outperform Start Price: $12.96 KERX Score: -0.55

Keryx still has some room to run. Their key product is very needed by the medical community and should provide an upward catalyst when it hits the market. I expect approval by the FDA.

Recs

0
Member Avatar SkepBioInvestor (95.94) Submitted: 5/15/2014 6:29:19 PM : Underperform Start Price: $12.89 KERX Score: +1.50

Zere-crap will get a CRL by June 7

Recs

0
Member Avatar chitownatiiive (< 20) Submitted: 1/30/2014 8:08:49 PM : Outperform Start Price: $15.51 KERX Score: -25.81

i feel it. im brand at trying ive attempted to study the market but have been lazy this is a lucky guess based on how its already moving upward and is rated 80% bullish

Recs

0
Member Avatar Litigation (< 20) Submitted: 3/16/2013 7:15:33 PM : Outperform Start Price: $7.25 KERX Score: +57.93

Price Target: $13

Recs

0
Member Avatar scrubs62074 (82.05) Submitted: 1/23/2013 2:03:57 PM : Outperform Start Price: $3.81 KERX Score: +223.86

High volume breakout 1/23/13

Recs

0
Member Avatar NHWeston102 (65.86) Submitted: 7/6/2012 10:13:26 PM : Outperform Start Price: $1.93 KERX Score: +559.73

Outclassed in all its categories but a fair buy-out candidates.

Recs

0
Member Avatar Robase06 (< 20) Submitted: 5/23/2012 10:12:36 PM : Outperform Start Price: $1.78 KERX Score: +616.37

Zerenex

Recs

0
Member Avatar TXKL (< 20) Submitted: 5/16/2012 4:05:00 PM : Outperform Start Price: $1.85 KERX Score: +587.56

Big buyout rumors.

Recs

0
Member Avatar someboy0808 (< 20) Submitted: 5/11/2012 6:47:34 PM : Outperform Start Price: $1.98 KERX Score: +540.64

Top line Positive phase 3 drug report from Japan, and 100million license fee, you know this company is not going down any time soon!

Recs

0
Member Avatar wcaddict (< 20) Submitted: 4/23/2012 12:10:52 PM : Outperform Start Price: $1.71 KERX Score: +652.50

news

Recs

0
Member Avatar Stef100000 (< 20) Submitted: 4/10/2012 1:22:13 PM : Underperform Start Price: $1.42 KERX Score: -815.18

No future

Recs

0
Member Avatar solanZRaider (< 20) Submitted: 4/2/2012 5:36:17 PM : Outperform Start Price: $1.69 KERX Score: +666.98

bravo

Recs

0
Member Avatar WRXkid (83.61) Submitted: 3/29/2012 2:01:49 PM : Outperform Start Price: $4.83 KERX Score: +138.52

Possible positive outcome of clinical trials for perifosine.

Recs

0
Member Avatar saulucy20 (< 20) Submitted: 3/16/2012 6:02:54 AM : Outperform Start Price: $4.18 KERX Score: +183.49

Phase 3 on Perifosine

Recs

0
Member Avatar RBuskey106 (44.92) Submitted: 3/14/2012 10:42:20 PM : Outperform Start Price: $4.10 KERX Score: +189.62

Betting on perifosine for the short term bump

Recs

0
Member Avatar KimLanners (< 20) Submitted: 10/14/2011 1:51:20 PM : Outperform Start Price: $2.79 KERX Score: +324.77

biotech

Recs

0
Member Avatar vaderblue (< 20) Submitted: 8/31/2011 5:00:26 PM : Outperform Start Price: $4.11 KERX Score: +167.81

I am an investor of Kerx for along time. I am hinting this is a must deal for them. Good news today but like
having babies, we must wait it out.

Results 1 - 20 of 73 : 1 2 3 4 Next »

Featured Broker Partners


Advertisement